Corbus Pharmaceuticals Holdings (CRBP) Net Equity Issued and Repurchased (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded Net Equity Issued and Repurchased of $2.85 million in Q3 2025, down 92.1% from $35.94 million a year earlier.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Net Equity Issued and Repurchased (2013 - 2025) Analysis & Trends
On a TTM basis, Corbus Pharmaceuticals Holdings' Net Equity Issued and Repurchased came in at $2.84 million as of Sep 30, 2025, down 98.4% year-over-year; for FY2024, it came in at $182.06 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 34.9% (FY2019 to FY2024).
- Across earlier years, Net Equity Issued and Repurchased came in at $53,000 in FY2023, $62.59 million in FY2021 (-56.0%) and $142.2 million in FY2020 (+249.6%).
- Quarterly Net Equity Issued and Repurchased has ranged from -$80,000 in Q3 2023 to $108.9 million in Q1 2024 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 50.64 Mn | -465.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.85 Mn |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | 35.94 Mn |
| Jun 30, 2024 | 37.23 Mn |
| Mar 31, 2024 | 108.90 Mn |
| Dec 31, 2023 | -74,000.00 |
| Sep 30, 2023 | -80,000.00 |
| Jun 30, 2023 | 169,944.00 |
| Mar 31, 2023 | 37,056.00 |
| Jun 30, 2021 | 50,000.00 |
| Mar 31, 2021 | 62.54 Mn |
| Dec 31, 2020 | 21.70 Mn |
| Sep 30, 2020 | 30.50 Mn |
| Jun 30, 2020 | 43.99 Mn |
| Mar 31, 2020 | 46.02 Mn |
| Dec 31, 2019 | -1.00 |
| Sep 30, 2019 | 80,100.00 |
| Jun 30, 2019 | 102,708.00 |
| Mar 31, 2019 | 40.49 Mn |
| Dec 31, 2018 | 10,000.00 |
API Access
Corbus Pharmaceuticals Holdings Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();